Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_assertion type Assertion NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_head.
- NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_assertion description "[Circulating ANXA2 in HCC patients was significantly higher than that of other liver diseases (P < 0.01) except metastatic liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_provenance.
- NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_assertion evidence source_evidence_literature NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_provenance.
- NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_assertion SIO_000772 23139605 NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_provenance.
- NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_assertion wasDerivedFrom befree-20150227 NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_provenance.
- NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_assertion wasGeneratedBy ECO_0000203 NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_provenance.